DANIELLE WESTGATE: Open Payments
NPI 1780983916 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,143 in 49 payments from 15 companies in 2025. Trend: 2023 $450 · 2024 $939 · 2025 $1,143
Food & beverage: $1,143
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $333 |
| Otsuka America Pharmaceutical, Inc. | 10 | $213 |
| Janssen Pharmaceuticals, Inc | 9 | $175 |
| ABBVIE INC. | 4 | $96 |
| E.R. Squibb & Sons, L.L.C. | 4 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $47 |
| Lilly USA, LLC | 2 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Alkermes, Inc. | 2 | $29 |
Products named: Auvelity, REXULTI, INVEGA SUSTENNA, VRAYLAR, COBENFY, CAPLYTA, ABILIFY MAINTENA, SPRAVATO.
Industry payments across PA — which companies pay providers there.
